Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,619,702
-
Share change
-
+1,667,932
-
Total reported value
-
$38,488,708
-
Put/Call ratio
-
66%
-
Price per share
-
$3.05
-
Number of holders
-
86
-
Value change
-
+$5,204,863
-
Number of buys
-
45
-
Number of sells
-
34
Institutional Holders of G1 THERAPEUTICS INC - COM (GTHX) as of Q4 2023
As of 31 Dec 2023,
G1 THERAPEUTICS INC - COM (GTHX) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,619,702 shares.
The largest 10 holders included
VANGUARD GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, RAYMOND JAMES & ASSOCIATES, GROUP ONE TRADING, L.P., D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, abrdn plc, and MARSHALL WACE, LLP.
This page lists
86
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.